Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1237-1254
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1237
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1237
Figure 3 Overexpression of HOXD-AS2 inhibits gastric cancer cell migration and invasion in vitro.
A: Transwell assays were performed to detect the effect of HOXD-AS2 on the migration and invasion of SGC-7901 and SNU-1 cells. The results revealed that overexpression of HOXD-AS2 inhibited the migration and invasion of SGC-7901 and SNU-1 cells; B: Wound healing assay further showed that overexpression of HOXD-AS2 inhibited gastric cancer cell migration and invasion. aP < 0.05, bP < 0.01. Data are shown as the mean ± SD. All the experiments were performed in triplicate.
- Citation: Yao L, Ye PC, Tan W, Luo YJ, Xiang WP, Liu ZL, Fu ZM, Lu F, Tang LH, Xiao JW. Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway. World J Gastrointest Oncol 2020; 12(11): 1237-1254
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1237.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1237